Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
83.74
+1.04 (1.26%)
At close: Oct 8, 2025, 4:00 PM EDT
82.07
-1.67 (-1.99%)
After-hours: Oct 8, 2025, 6:08 PM EDT
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 8 analysts that cover Merit Medical Systems stock have a consensus rating of "Strong Buy" and an average price target of $107.5, which forecasts a 28.37% increase in the stock price over the next year. The lowest target is $100 and the highest is $120.
Price Target: $107.5 (+28.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Merit Medical Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $103 | Buy | Maintains | $103 | +23.00% | Oct 7, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $103 | Buy | Maintains | $103 | +23.00% | Sep 23, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $108 → $100 | Buy | Maintains | $108 → $100 | +19.42% | Jul 31, 2025 |
| Raymond James | Raymond James | Buy Maintains $108 → $102 | Buy | Maintains | $108 → $102 | +21.81% | Jul 31, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $110 → $105 | Buy | Maintains | $110 → $105 | +25.39% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
1.53B
from 1.36B
Increased by 12.79%
Revenue Next Year
1.63B
from 1.53B
Increased by 6.34%
EPS This Year
3.68
from 2.03
Increased by 81.19%
EPS Next Year
4.04
from 3.68
Increased by 9.87%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6B | 1.7B | |||
| Avg | 1.5B | 1.6B | |||
| Low | 1.5B | 1.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.5% | 10.7% | |||
| Avg | 12.8% | 6.3% | |||
| Low | 8.1% | 0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.83 | 4.37 | |||
| Avg | 3.68 | 4.04 | |||
| Low | 3.26 | 3.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 88.8% | 18.8% | |||
| Avg | 81.2% | 9.9% | |||
| Low | 60.8% | 2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.